Anti-tumor effects of metformin on head and neck carcinoma cell lines: A systematic review

Metformin is commonly used for treating type 2 diabetes, and may also reduce cancer risk. Previous studies have demonstrated the association between metformin use and a decreased risk of head and neck cancer. Therefore, the aim of the present systematic review was to summarize the available literatu...

Descripción completa

Detalles Bibliográficos
Autores principales: Rêgo, Daniela Fortunato, Elias, Silvia Taveira, Amato, AngéLica Amorim, Canto, Graziela De Luca, Guerra, Eliete Neves Silva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351305/
https://www.ncbi.nlm.nih.gov/pubmed/28356929
http://dx.doi.org/10.3892/ol.2016.5526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351305/
https://www.ncbi.nlm.nih.gov/pubmed/28356929
http://dx.doi.org/10.3892/ol.2016.5526

Ejemplares similares